|
1
|
4-(6-Hydroxy-2-naphthyl)-1,3-bezendiol: a potent, new tyrosinase inhibitor.
|
Biol Pharm Bull
|
2007
|
1.40
|
|
2
|
Apoptosis and modulation of cell cycle control by synthetic derivatives of ursodeoxycholic acid and chenodeoxycholic acid in human prostate cancer cells.
|
Cancer Lett
|
2003
|
0.92
|
|
3
|
A novel resveratrol derivative, HS1793, overcomes the resistance conferred by Bcl-2 in human leukemic U937 cells.
|
Biochem Pharmacol
|
2009
|
0.90
|
|
4
|
3-(4'-hydroxyl-3',5'-dimethoxyphenyl)propionic acid, an active principle of kimchi, inhibits development of atherosclerosis in rabbits.
|
J Agric Food Chem
|
2007
|
0.90
|
|
5
|
Orphan nuclear receptor Nur77 translocates to mitochondria in the early phase of apoptosis induced by synthetic chenodeoxycholic acid derivatives in human stomach cancer cell line SNU-1.
|
Ann N Y Acad Sci
|
2003
|
0.89
|
|
6
|
Synthetic bile acid derivatives inhibit cell proliferation and induce apoptosis in HT-29 human colon cancer cells.
|
Int J Oncol
|
2004
|
0.87
|
|
7
|
HS-1793, a recently developed resveratrol analogue protects rat heart against hypoxia/reoxygenation injury via attenuating mitochondrial damage.
|
Bioorg Med Chem Lett
|
2013
|
0.85
|
|
8
|
A chenodeoxycholic derivative, HS-1200, induces apoptosis and cell cycle modulation via Egr-1 gene expression control on human hepatoma cells.
|
Cancer Lett
|
2008
|
0.85
|
|
9
|
Dual stimuli-responsive poly(N-isopropylacrylamide)-b-poly(L-histidine) chimeric materials for the controlled delivery of doxorubicin into liver carcinoma.
|
Biomacromolecules
|
2013
|
0.84
|
|
10
|
Synthetic bile acid derivatives induce apoptosis through a c-Jun N-terminal kinase and NF-kappaB-dependent process in human cervical carcinoma cells.
|
Cancer Lett
|
2005
|
0.84
|
|
11
|
Synthetic chenodeoxycholic acid derivatives inhibit glioblastoma multiform tumor growth in vitro and in vivo.
|
Int J Oncol
|
2005
|
0.83
|
|
12
|
Differential effects of resveratrol and novel resveratrol derivative, HS-1793, on endoplasmic reticulum stress-mediated apoptosis and Akt inactivation.
|
Int J Oncol
|
2010
|
0.83
|
|
13
|
Syntheses of hydroxy substituted 2-phenyl-naphthalenes as inhibitors of tyrosinase.
|
Bioorg Med Chem Lett
|
2006
|
0.82
|
|
14
|
A novel resveratrol analogue HS-1793 treatment overcomes the resistance conferred by Bcl-2 and is associated with the formation of mature PML nuclear bodies in renal clear cell carcinoma Caki-1 cells.
|
Int J Oncol
|
2009
|
0.80
|
|
15
|
An analogue of resveratrol HS-1793 exhibits anticancer activity against MCF-7 cells via inhibition of mitochondrial biogenesis gene expression.
|
Mol Cells
|
2012
|
0.80
|
|
16
|
Resveratrol analogue HS-1793 induces the modulation of tumor-derived T cells.
|
Exp Ther Med
|
2012
|
0.79
|
|
17
|
The novel resveratrol analog HS-1793-induced polyploid LNCaP prostate cancer cells are vulnerable to downregulation of Bcl-xL.
|
Int J Oncol
|
2011
|
0.78
|
|
18
|
Poly(L-histidine)-tagged 5-aminolevulinic acid prodrugs: new photosensitizing precursors of protoporphyrin IX for photodynamic colon cancer therapy.
|
Int J Nanomedicine
|
2012
|
0.78
|
|
19
|
Efficacy on anaplastic thyroid carcinoma of valproic acid alone or in combination with doxorubicin, a synthetic chenodeoxycholic acid derivative, or lactacystin.
|
Int J Oncol
|
2009
|
0.78
|
|
20
|
A newly synthesized, potent tyrosinase inhibitor: 5-(6-hydroxy-2-naphthyl)-1,2,3-benzenetriol.
|
Bioorg Med Chem Lett
|
2010
|
0.78
|
|
21
|
A novel chenodeoxycholic derivative HS-1200 enhances radiation-induced apoptosis in MCF-7 cells.
|
Oncol Rep
|
2007
|
0.78
|
|
22
|
High open circuit voltage organic photovoltaic cells fabricated using 9,9'-bifluorenylidene as a non-fullerene type electron acceptor.
|
Chem Commun (Camb)
|
2013
|
0.77
|
|
23
|
Easy synthesis of hierarchical carbon spheres with superior capacitive performance in supercapacitors.
|
Langmuir
|
2013
|
0.76
|
|
24
|
Inhibitory effects of 6-(3-hydroxyphenyl)-2-naphthol on tyrosinase activity and melanin synthesis.
|
Arch Pharm Res
|
2009
|
0.76
|
|
25
|
Fabrication of nanotubules and microspheres from the self-assembly of amphiphilic monochain stearic acid derivatives.
|
Langmuir
|
2010
|
0.75
|
|
26
|
Crosslinked poly(ethylene glycol) hydrogels with degradable phosphamide linkers used as a drug carrier in cancer therapy.
|
Macromol Biosci
|
2013
|
0.75
|
|
27
|
A Micellar Complex of a Conjugated Polyelectrolyte for Efficient FRET to Dye-Labeled DNA.
|
Macromol Rapid Commun
|
2009
|
0.75
|
|
28
|
Poly(2-hydroxyethyl methacrylate)-b-poly(L-Lysine) cationic hybrid materials for non-viral gene delivery in NIH 3T3 mouse embryonic fibroblasts.
|
Macromol Biosci
|
2014
|
0.75
|
|
29
|
Lipo-poly(L-histidine) hybrid materials with pH-sensitivity, intracellular delivery efficiency, and intrinsic targetability to cancer cells.
|
Macromol Rapid Commun
|
2014
|
0.75
|
|
30
|
Enhanced open circuit voltage by hydrophilic ionic liquids as buffer layer in conjugated polymer-nanoporous titania hybrid solar cells.
|
Phys Chem Chem Phys
|
2010
|
0.75
|
|
31
|
Fabrication of microspheres via solvent volatization induced aggregation of self-assembled nanomicellar structures and their use as a pH-dependent drug release system.
|
Langmuir
|
2012
|
0.75
|
|
32
|
Poly(PEGA)-b-poly(l-lysine)-b-poly(l-histidine) Hybrid Vesicles for Tumoral pH-Triggered Intracellular Delivery of Doxorubicin Hydrochloride.
|
ACS Appl Mater Interfaces
|
2015
|
0.75
|
|
33
|
Synthetic chenodeoxycholic acid derivative HS-1200-induced apoptosis of p815 mastocytoma cells is augmented by co-treatment with lactacystin.
|
Anticancer Drugs
|
2003
|
0.75
|
|
34
|
Hyperbranched polyglycidol assisted green synthetic protocols for the preparation of multifunctional metal nanoparticles.
|
Langmuir
|
2010
|
0.75
|
|
35
|
Counterion effects on fluorescence energy transfer in conjugated polyelectrolyte-based DNA detection.
|
J Phys Chem B
|
2009
|
0.75
|
|
36
|
The Electrical Properties for Phenolic Isocyanate-Modified Bisphenol-Based Epoxy Resins Comprising Benzoate Group.
|
J Nanosci Nanotechnol
|
2016
|
0.75
|